Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 4/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25845438 | 0.83 | MTNR1A (0.38) | MTNR1AMTNR1BMAPK1KDM4EHIF1A | |
| SCHEMBL19821886 | 0.78 | KDM4E (0.39) | MTNR1AMTNR1BMAPK1KDM4EHIF1A | |
| SCHEMBL21579178 | 0.76 | MAPK1 (0.43) | MTNR1AMTNR1BMAPK1KDM4EHIF1A | |
| SCHEMBL13585409 | 0.73 | ACHE (0.43) | MTNR1AMTNR1BALDH1A1GAAL3MBTL1 | |
| SCHEMBL15965828 | 0.73 | MTNR1A (0.43) | MTNR1AMTNR1BMAPK1KDM4EHIF1A | |
| SCHEMBL19598186 | 0.71 | MTNR1A (0.36) | MTNR1AMTNR1BMAPK1KDM4EHIF1A | |
| SCHEMBL14521352 | 0.69 | KDM4E (0.45) | MTNR1AMTNR1BMAPK1KDM4EHIF1A | |
| SCHEMBL25153643 | 0.69 | POLB (0.35) | KDM4E | |
| SCHEMBL279485 | 0.67 | MAPK1 (0.50) | MTNR1AMTNR1BMAPK1KDM4EHIF1A | |
| SCHEMBL24144844 | 0.67 | CYP4F2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201118-A1 | PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY | THE UNIVERSITY OF CHICAGO | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201118-A1 | PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY | SI, VIP, FAAH | MTNR1A 1482/4885MTNR1B 2134/4885MAPK1 2935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.